Shaaaw
liked
No megadeals in biotech so far this yr, but on track for record amount >$1 bil deals,
2 biggest deals this yr:
$Vertex Pharmaceuticals(VRTX.US$ paid $4.9 bil for $Alpine Immune(ALPN.US$
$Gilead Sciences(GILD.US$ paid $4.3 bil for $CBAY
Bolt-on deals likely to continue to be the dominant story in 2024, which means we could also see more of this trend...
Last yr 84% of M&A deal dollars were for Biotechs w/ Phase 3 & Marketed assets,
In the first four months of 2024 56% of M&A deal dollar went towards P...
2 biggest deals this yr:
$Vertex Pharmaceuticals(VRTX.US$ paid $4.9 bil for $Alpine Immune(ALPN.US$
$Gilead Sciences(GILD.US$ paid $4.3 bil for $CBAY
Bolt-on deals likely to continue to be the dominant story in 2024, which means we could also see more of this trend...
Last yr 84% of M&A deal dollars were for Biotechs w/ Phase 3 & Marketed assets,
In the first four months of 2024 56% of M&A deal dollar went towards P...
6
Top 10 drug companies raked in NEARLY TRIPLE the revenue in 2023 ($491B) vs 2013 ($165B) 2013 vs. 2023.
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
3
1
Shaaaw
liked
$Viking Therapeutics(VKTX.US$ $Novo-Nordisk A/S(NVO.US$ $Eli Lilly and Co(LLY.US$
Chart- show major competitors in obesity and subsequent weight loss over time
Pay attention to Duration in weeks
$Viking Therapeutics(VKTX.US$ best in class drug for obesity with best results (weight loss) in least amount of time vs other companies.
⬇️⬇️
Chart- show major competitors in obesity and subsequent weight loss over time
Pay attention to Duration in weeks
$Viking Therapeutics(VKTX.US$ best in class drug for obesity with best results (weight loss) in least amount of time vs other companies.
⬇️⬇️
3
Shaaaw
liked
Top companies and drugs by sales in 2023 from Nature Reviews Drug Discovery.
$Eli Lilly and Co(LLY.US$ and $Novo-Nordisk A/S(NVO.US$ are not on the list (they will be next year of course...). Just shows how forward looking our industry is as both have higher market caps than any of the top 10 companies
$Eli Lilly and Co(LLY.US$ and $Novo-Nordisk A/S(NVO.US$ are not on the list (they will be next year of course...). Just shows how forward looking our industry is as both have higher market caps than any of the top 10 companies
4
Shaaaw
liked
👉 Key Highlights:
📍 Nonfarm payrolls soar by 303,000 in March, outpacing expectations.
📍 February's job additions revised down slightly to 270,000.
📍 Unemployment rate falls to 3.8%, indicating a robust job market.
📍 S&P 500 futures point to a positive Wall Street open following the report.
📍 10-year Treasury yield jumps 8.9 basis points, reflecting bond market reaction.
📍 Dollar index strengthens by 0.3%, signaling currency mar...
📍 Nonfarm payrolls soar by 303,000 in March, outpacing expectations.
📍 February's job additions revised down slightly to 270,000.
📍 Unemployment rate falls to 3.8%, indicating a robust job market.
📍 S&P 500 futures point to a positive Wall Street open following the report.
📍 10-year Treasury yield jumps 8.9 basis points, reflecting bond market reaction.
📍 Dollar index strengthens by 0.3%, signaling currency mar...
3
Shaaaw
liked
$Meta Platforms(META.US$
👉 Key Highlights:
📍 Instagram contributed 30% to Meta's revenue in the first half of 2022.
📍 $22 billion revenue from Instagram in 2020, making up 26% of Meta's total sales.
📍 Revenue increased to $32.4 billion in 2021, accounting for 27% of the business.
📍 First six months of 2022 saw Instagram generate $16.5 billion.
📍 Instagram's growth outpaces other Meta platforms, showcasing the app's expanding financial infl...
👉 Key Highlights:
📍 Instagram contributed 30% to Meta's revenue in the first half of 2022.
📍 $22 billion revenue from Instagram in 2020, making up 26% of Meta's total sales.
📍 Revenue increased to $32.4 billion in 2021, accounting for 27% of the business.
📍 First six months of 2022 saw Instagram generate $16.5 billion.
📍 Instagram's growth outpaces other Meta platforms, showcasing the app's expanding financial infl...
4
Shaaaw
liked
$AMC Entertainment(AMC.US$
👉 Key Highlights:
📍 Adam Aron, CEO of AMC Theatres, sees compensation rise to $25.4 million in 2023.
📍 Salary boost from $23.7 million in 2022 and $18.9 million in 2021.
📍 Package includes $1.5 million base salary, $17.9 million in stock awards, and $6 million in incentives.
📍 AMC leverages meme stock surge in 2021 to strengthen financials and expand revenue streams.
📍 Aron's base salary remains steady at $1.5 mil...
👉 Key Highlights:
📍 Adam Aron, CEO of AMC Theatres, sees compensation rise to $25.4 million in 2023.
📍 Salary boost from $23.7 million in 2022 and $18.9 million in 2021.
📍 Package includes $1.5 million base salary, $17.9 million in stock awards, and $6 million in incentives.
📍 AMC leverages meme stock surge in 2021 to strengthen financials and expand revenue streams.
📍 Aron's base salary remains steady at $1.5 mil...
2
6
Shaaaw
liked
$Novo-Nordisk A/S(NVO.US$ & $Eli Lilly and Co(LLY.US$ 's MCap increased by $285 bil in Q1 2024 alone, driven mostly by growth of the GLP-1 franchises,
Revenue from both companies GLP-1 drugs totaled $33.6 bil last yr, an impressive number that almost certainly will grow this yr,
But let's put that $285 bil incr in mkt value into perspective,
$AbbVie(ABBV.US$ has a $315 bil MCap, not much bigger than the combined Q1 incr in mkt value for LLY & NVO,
ABBV had $54 bil in revenue in 2023, compared ...
Revenue from both companies GLP-1 drugs totaled $33.6 bil last yr, an impressive number that almost certainly will grow this yr,
But let's put that $285 bil incr in mkt value into perspective,
$AbbVie(ABBV.US$ has a $315 bil MCap, not much bigger than the combined Q1 incr in mkt value for LLY & NVO,
ABBV had $54 bil in revenue in 2023, compared ...
4
$Viking Therapeutics(VKTX.US$ obesity market has all the momentum.
Likely suitors:
- $Pfizer(PFE.US$ - just pulled their Ph3 trial from Danuglipron twice daily dosing due to AE’s. Wants in obesity market.
- $Eli Lilly and Co(LLY.US$ - could own the obesity market with $Viking Therapeutics(VKTX.US$ and tirzepatide. Has speculation interest. Approaching $1T market cap soon.
- $Merck & Co(MRK.US$ - currently studying efinopegdutide. Wants a piece of the pie. Could immediately be a major player with...
Likely suitors:
- $Pfizer(PFE.US$ - just pulled their Ph3 trial from Danuglipron twice daily dosing due to AE’s. Wants in obesity market.
- $Eli Lilly and Co(LLY.US$ - could own the obesity market with $Viking Therapeutics(VKTX.US$ and tirzepatide. Has speculation interest. Approaching $1T market cap soon.
- $Merck & Co(MRK.US$ - currently studying efinopegdutide. Wants a piece of the pie. Could immediately be a major player with...
2